Editas Medicine (EDIT) Return on Capital Employed Growth (5y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11,875.00 |
| Jun 30, 2025 | -10,936.00 |
| Mar 31, 2025 | -7,613.00 |
| Dec 31, 2024 | -6,057.00 |
| Sep 30, 2024 | -3,753.00 |
| Jun 30, 2024 | -2,581.00 |
| Mar 31, 2024 | -1,430.00 |
| Dec 31, 2023 | -767.00 |
| Sep 30, 2023 | -1,357.00 |
| Jun 30, 2023 | -1,505.00 |
| Mar 31, 2023 | -2,017.00 |
| Sep 30, 2022 | -199.00 |
| Jun 30, 2022 | 221.00 |
| Mar 31, 2022 | 1,154.00 |
| Dec 31, 2021 | 1,828.00 |
| Sep 30, 2021 | -131.00 |
| Jun 30, 2021 | 2.00 |
| Mar 31, 2021 | 172.00 |